🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Guardant Health, Inc.

GH Healthcare
$162.94 $-3.72 (-2.23%)
Market Cap: $21.87 B
Gurus Holding
7
Popularity Rank
#1208
% of Shares Held
1.20%
Net Activity (Q2 2026)
+$8.25 M

Guru Ownership Trend

Guru Analysis for Guardant Health, Inc. (GH)

Guardant Health, Inc. (GH), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $262.17 M.

Top institutional holders include Steven Cohen and Catherine Wood.

Institutional sentiment is currently Bullish. This is evidenced by a $8.25 M net inflow during the quarter.

Recent activity highlights Joel Greenblatt who opened a new position. Conversely, Ray Dalio reduced exposure by 68.2%.

Key Holders

Top 5 by Value

$138.15 M
$75.98 M
$18.25 M
$5.35 M
$3.03 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$42.25 M
Total Buy Value
New Buys 2
Additions 3
-$34 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
5

FAQs for Guardant Health, Inc. (GH)

Major holders include Steven Cohen ($138.15 M), Catherine Wood ($75.98 M), Cliff Asness ($18.25 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 1.61 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.25 M, with 5 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited GH. The total reported sell value was $34 M.

Yes, 2 managers opened new positions in GH, and 3 increased their existing holdings. The total reported buy value was $42.25 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.15% Add 32.3% 920,807 $138.15 M Q2 2026
0.49% Add 4.1% 506,416 $75.98 M Q2 2026
0.01% Reduce -7.3% 121,668 $18.25 M Q2 2026
0.04% Add 88.7% 35,629 $5.35 M Q2 2026
0.01% New Buy 20,207 $3.03 M Q2 2026
0.00% Reduce -68.2% 4,244 $636,727 Q2 2026
0.00% New Buy 16 $2,460 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form